The efficacy and safety of vonoprazan in quadruple therapy for <i>Helicobacter pylori</i> eradication: a comparative study.

Gastroenterol Rep (Oxf) · 2024 · PMC11018536 · PMID 38628396

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

As shown in Table 2 , eradication rates showed a decreasing trend in patients aged > 60 years; however, the eradication efficacy showed no significant difference between the VOD and VTD groups or between the VOD and PPI groups in the various age subgroups (all P > 0.05).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.